[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

Wada, Seiki; Fukawa, Takeshi; Kamiya, Sadahiro

Wada, Seiki; Fukawa, Takeshi; Kamiya, Sadahiro.

Affiliation

Wada S; Department of Clinical Science, Faculty of Pharmaceutical Sciences, Josai International University.

Nihon Rinsho ; 65 Suppl 9: 421-5, 2007 Nov 28.

Article in Ja | MEDLINE | ID: mdl-18161143

Subject(s)

Bone Density Conservation Agents; Diphosphonates; Drug Design; Imidazoles; Osteoporosis/drug therapy; Research; Bone Density; Bone Density Conservation Agents/administration & dosage; Bone Density Conservation Agents/adverse effects; Bone Density Conservation Agents/therapeutic use; Bone and Bones/metabolism; Diphosphonates/administration & dosage; Diphosphonates/adverse effects; Diphosphonates/therapeutic use; Humans; Imidazoles/administration & dosage; Imidazoles/adverse effects; Imidazoles/therapeutic use; Osteoporosis/etiology; Osteoporosis/metabolism; Zoledronic Acid

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Research / Drug Design / Diphosphonates / Bone Density Conservation Agents / Imidazoles Type of study: Etiology_studies Limits: Humans Language: Ja Journal: Nihon Rinsho Year: 2007 Document type: Article Country of publication: JAPAN / JAPON / JAPÃO / JP

Search on Google

Add to My VHL

XML

PubMed Links